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Recruitment of Nck by CD3 Reveals a Ligand-
Induced Conformational Change Essential for
T Cell Receptor Signaling and Synapse Formation
homodimer (Jacobs, 1997). When TCR/ interacts with
the antigen/MHC complex, it somehow transmits this
information to the CD3 components. Unlike the TCR/
heterodimer, the CD3 components have long cyto-
plasmic tails able to interact with intracellular signaling
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cluding the tyrosine kinase ZAP70 (reviewed in Lin andSpain
Weiss, 2001). It is commonly believed that phosphoryla-
tion of the ITAMs is the earliest activation event upon
ligand binding to TCR-CD3. However, although se-Summary
quences outside the ITAMs have not been directly impli-
cated in T cell activation, the entire cytoplasmic tails ofHow membrane receptors initiate signal transduction
upon ligand binding is a matter of intense scrutiny. the CD3 subunits have been highly conserved through-
out evolution (Gobel and Bolliger, 2000), suggesting theyThe T cell receptor complex (TCR-CD3) is composed
of TCR/ ligand binding subunits bound to the CD3 may play important roles in T cell activation.
We used a yeast two-hybrid approach to search forsubunits responsible for signal transduction. Although
it has long been speculated that TCR-CD3 may undergo effectors in T cell activation that bind to non-ITAM re-
gions of the cytoplasmic tails of CD3 subunits. We founda conformational change, confirmation is still lacking.
We present strong evidence that ligand engagement that Nck, an adaptor protein thought to play an important
role in receptor-promoted remodeling of the actin cy-of TCR-CD3 induces a conformational change that
exposes a proline-rich sequence in CD3 and results toskeleton (reviewed in Buday, 1999), specifically binds
to a proline-rich sequence contained exclusively in thein recruitment of the adaptor protein Nck. This occurs
earlier than and independently of tyrosine kinase acti- cytoplasmic tail of CD3. Through characterization of
this interaction, we show that TCR-CD3 undergoes avation. Finally, by interfering with Nck-CD3 associa-
tion in vivo, we demonstrate that TCR-CD3 recruitment ligand-induced conformational change that results in
Nck binding. We propose a model of T cell activationof Nck is critical for maturation of the immune synapse
and for T cell activation. in which binding of antigen/MHC to TCR-CD3 has a dual
effect: ligand-induced crosslinking resulting in activa-
tion of tyrosine kinases and subsequent phosphoryla-Introduction
tion of the ITAMs, and a ligand-induced conformational
change allowing Nck binding. Both effects are requiredUpon ligand binding, most cell surface receptors initiate
signaling cascades inside cells either by undergoing a for full T cell activation.
conformational change or by clustering (Cochran et al.,
2001; Jiang and Hunter, 1999; Reth, 2001; Weiss and Results
Schlessinger, 1998). The T cell antigen receptor complex
(TCR-CD3) recognizes specific antigens bound to major Nck Binds to CD3 upon Ligand-Mediated
histocompatibility complex molecules (MHC) present on TCR Triggering
antigen-presenting cells (APC). At the T cell:APC inter- We identified Nck as a protein that interacts with the
face, the two plasma membranes form a structure CD3 cytoplasmic tail by using the yeast two-hybrid
known as the immunological synapse (IS) (reviewed in SOS-recruitment system (Aronheim, 2001). Nck bound
Dustin and Cooper, 2000). The TCR-CD3 concentrates specifically to a bait construct consisting of two copies
within the IS, forming a central supramolecular activa- in tandem of the cytoplasmic tail of human CD3, and
tion cluster (cSMAC) surrounded by a ring of adhesion also to a single copy (data not shown). We next used a
molecules (Monks et al., 1998). The formation of the IS GST-Nck fusion protein in pull-down assays of lysates
requires TCR-CD3 signaling and rearrangement of the of COS cells transfected with different CD3 subunits.
actin cytoskeleton and is believed to be necessary for GST-Nck precipitated CD3 but not CD3, CD3, or
the TCR-CD3 to give a sustained signal needed for T CD3, indicating that CD3 is the only CD3 subunit that
cell activation. The TCR-CD3 complex is composed of a interacts with Nck (Figure 1A). To assess Nck interac-
TCR/ heterodimer (or TCR/ in  T cells) associated tion with the full TCR-CD3 in T cells, immunoprecipita-
with four polypeptides organized as dimers: the hetero- tion with anti-TCR was carried out in the human T cell
dimers CD3-CD3 and CD3-CD3 and the CD3-CD3 line Jurkat, followed by immunoblotting for Nck (Figure
1B). Nck was coprecipitated with TCR-CD3 from cells
previously activated by 5 min incubation with the stimu-3 Correspondence: balarcon@cbm.uam.es
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Figure 1. Nck Is Recruited to CD3 upon Li-
gand Binding to TCR-CD3
(A) Nck binds to CD3 but not to other CD3
subunits. COS cells transfected with the indi-
cated constructs were lysed, and a pull-down
(pd) with GST-Nck fusion protein followed by
immunoblotting (IB) with anti-Flag or anti-
CD3 antibodies was performed. A fraction
of the total lysate of each transfectant was
IB with the corresponding antibody to dem-
onstrate the presence of the protein.
(B) Nck is recruited to TCR-CD3 upon stimula-
tion of intact T cells. Jurkat cells were unstim-
ulated (0) or stimulated for 5 min with 10 g/
ml of the anti-CD3 antibody UCHT1. The TCR
complex was immunoprecipitated (IP) with
anti-TCR Jovi.1 and IB carried out with anti-
Nck antibody. A fraction of the total lysate
(TL) and a preclear with nonimmune serum
(NIS) were run in parallel. The arrowhead indi-
cates Nck.
(C) Transfected Nck binds to the endogenous
TCR-CD3 upon activation. Jurkat cells were
mock-transfected or transfected with a vec-
tor expressing HA-tagged Nck. IP was with
UCHT1 and IB with anti-HA.
(D) Nck binds constitutively to immobilized
CD3. A pd with GST or GST-was performed
from HA-Nck-transfected Jurkat cells and
followed by IB with anti-HA.
(E) Antibody engagement of TCR-CD3 in-
duces its association with immobilized Nck.
Flag-CD3-expressing Jurkat cells were stim-
ulated with UCHT1, and TCR-CD3 was pd
with GST-Nck. TCR was revealed by IB with
anti-Flag and anti-CD3.
(F) Antigen stimulation promotes Nck recruitment to the TCR in thymic and splenic murine T cells. Thymocytes and spleen cells from AND-
TCR transgenic mice were stimulated by incubation for 30 min with I-Ek-expressing DCEK APCs previously loaded with PCC antigen () or
with unloaded APC (	). PCC corresponded to a peptide with amino acids 88–100 of pigeon cytochrome C. IP was performed with anti-TCR
(H57) and IB with anti-Nck. The membrane was reprobed with anti-CD3 as a loading control.
latory anti-CD3 antibody UCHT1, but not from unstimu- cipitation with anti-TCR followed by immunoblotting
with anti-Nck showed that antigen/MHC engagementlated cells. This result was confirmed by immunoprecipi-
tation with anti-CD3 from cells transiently transfected of TCR-CD3 induces recruitment of endogenous Nck
(Figure 1F). Likewise, stimulation of human peripheralwith HA-tagged Nck: immunoblotting with anti-HA only
revealed the presence of Nck in anti-CD3 immunopre- blood T lymphocytes and murine thymic and spleen T
cells with anti-CD3 antibodies promoted CD3 bindingcipitates from UCHT1-stimulated cells (Figure 1C). Stim-
ulation-dependent binding of Nck to CD3 could reflect a to GST-Nck (data not shown). These results indicate
that engagement of TCR-CD3 with antibodies or antigenneed for modification of Nck or of the TCR-CD3 complex
itself. Nck associated with a fusion protein of GST and results in a modification of the TCR-CD3 complex that
allows recruitment of Nck to CD3.the CD3 cytoplasmic tail (GST-) independently of stim-
ulation (Figure 1D). For the reverse experiment, we used
Jurkat T cells transfected with an epitope-tagged form The N-Terminal SH3 Domain of Nck Binds
to a Proline-Rich Sequence in CD3of CD3. Pull-down with GST-Nck followed by immu-
noblotting with anti-flag antibody revealed the associa- To understand the molecular basis for dependence of
the Nck-CD3 interaction on TCR-CD3 engagement, wetion of endogenous CD3 with immobilized Nck to be
dependent on TCR-CD3 triggering (Figure 1E). In the performed pull-down experiments with GST-Nck from
COS cells transfected with deletion mutants encom-same experiment we found that binding of TCR-CD3 to
Nck could also be monitored by immunoblotting with passing the cytoplasmic tail of CD3 (Figure 2A). Nck
interacted with wild-type CD3 and mutants 7, 8, 11,an anti-CD3 antibody. Because CD3 is the last subunit
to be assembled into the TCR-CD3 complex (reviewed and 12, but not with mutants 9 and 10 (Figure 2B, top).
A proline-rich sequence (PRS) absent from all other CD3in Jacobs, 1997), these results suggest that antibody
engagement induces a modification in TCR-CD3 that subunits is contained within the region of CD3 deleted
in these mutants (Figure 2A). Deletion of this sequenceallows binding of the whole complex to Nck.
To determine whether Nck recruitment could be repro- abolishes Nck binding (Figure 2C). Direct Nck-PRS bind-
ing was shown by passing a Jurkat cell extract throughduced with more physiological stimuli and in other T
cells, AND-TCR transgenic thymic and splenic T cells a column containing an immobilized peptide corre-
sponding to the PRS (pep 25) (Figures 2A and 2D). Bind-were stimulated with antigen-loaded APCs. Immunopre-
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Figure 2. Nck Binds to the PRS of CD3
(A) Map of deletions performed in the cytoplasmic tail of human CD3. The amino acid sequence of the cytoplasmic tail of the CD3 chain in
different species is compared. Conserved amino acids are in plain black type and nonconserved residues in gray. Amino acids corresponding
either to the PRS or to the ITAM are in bold type. Sequences deleted in the human CD3 mutants are indicated by a broken line and the
corresponding number. The sequences of peptides 7, 8, and 25 used for (D) are also shown.
(B and C) Characterization of the Nck binding sequence in CD3. COS cells were not transfected (nt) or were transfected with wild-type CD3
(wt) or the deletion mutants d7 to d16. Pd with GST-Nck was performed after metabolic labeling with 35S-methionine. PhosphoImager images
are shown (top). IP with anti-CD3 SP34 was performed as a control for transfection (bottom).
(D) Nck binds to the PRS. Jurkat cell lysate was passed through columns of immobilized peptides 7, 8, and 25. After washing, 0.5 ml fractions
of eluate were taken for IB with anti-Nck.
(E) Nck and Nck can associate with TCR-CD3. GST-Nck and GST-Nck beads were used for pd of the TCR from lysates of unstimulated
and UCHT1-stimulated Jurkat cells.
ing to a larger peptide (pep 8) (Figures 2A and 2D) was (Figure 2E). Consequently, constructs expressing all or
part of Nck or Nck were used indistinctly for furtherstronger, suggesting sequences outside the PRS may
influence its conformation. experiments. Since Nck contains three SH3 domains, it
seemed likely that the Nck-CD3 interaction was medi-Two human Nck genes have been described, sharing
67% homology (Buday, 1999). They show identical orga- ated by binding of one or several of these to the PRS
of CD3. In support of this, a truncated form of Ncknization in three SH3 domains and a C-terminal SH2
domain. Although we initially identified Nck in the two- lacking the SH2 domain bound to CD3 in the TCR-
CD3 complex in an inducible fashion, and a GST fusionhybrid screen, both forms bind comparably to TCR-CD3
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was also inducible, indicating that SH3.1 is responsible
for the association of Nck with CD3. To control for
specificity, we performed pull-down experiments with
the three Nck SH3 domains on 35S-methionine-labeled
Jurkat cell lysates. The TCR-CD3 complex bound exclu-
sively, and in an inducible manner, to the SH3.1 domain
of Nck (Figure 3B), whereas the intermediate (SH3.2)
and C-terminal (SH3.3) domains bound to a variety of
other proteins in a constitutive fashion. The specificity
of interaction was also revealed in reverse, i.e., GST-
associated to Nck and not to other SH3 domain-con-
taining proteins (Figure 3C).
The Change in the TCR-CD3 Complex that
Promotes Nck Binding Is Earlier Than and
Independent of Tyrosine Phosphorylation
The fact that association between Nck and CD3 is me-
diated by a PRS-SH3 interaction made it hard to explain
the inducibility of Nck recruitment to TCR-CD3. Since
the PRS in CD3 is located near the ITAM, a possible
explanation was that tyrosine phosphorylation here
somehow influences the accessibility of the PRS to Nck.
We tested this hypothesis with PTK activators and inhib-
itors. First, Jurkat cells were incubated with pervanadate
(PV), which increases the level of tyrosine phosphoryla-
tion and induces a series of proximal T cell activation
events closely resembling those induced by TCR-CD3-
dependent stimuli (Secrist et al., 1993). Unlike anti-CD3
antibodies, stimulation with PV did not promote associa-
tion of TCR-CD3 with GST-SH3.1 (Figure 4A, top left).
PV activity was confirmed by immunoprecipitation with
anti-phosphotyrosine followed by immunoblotting with
the same antibody (Figure 4A, bottom left). Second, Jur-
kat cells were incubated with PP2, a potent inhibitor of
src family PTKs (Hanke et al., 1996) such as Lck and
Fyn. PP2 completely prevented tyrosine phosphoryla-
tion elicited upon antibody-mediated engagement of
TCR-CD3 (Figure 4A, bottom right), whereas the associ-
ation of TCR-CD3 with Nck was unaffected (Figure 4A,
top right). A similar result was obtained when the recruit-
ment of transfected Nck to TCR-CD3 was analyzed (Fig-
ure 4B). Thus, Nck binding to the TCR-CD3 complex
appears to involve changes in the complex that are inde-
pendent of PTK activity.
Activation of src family PTKs and tyrosine phosphory-
lation of ITAMs are believed to be the earliest eventsFigure 3. The Amino-Terminal SH3 Domain of Nck Binds Specifi-
elicited upon TCR-CD3 engagement (Lin and Weiss,cally to the PRS
2001). As Nck binding is independent of tyrosine phos-(A) Identification of the CD3 binding domain in Nck. The indicated
phorylation, we assessed the time courses of both pro-GST-Nck domain fusion proteins were used to pull down TCR-CD3,
revealed by IB with anti-CD3. cesses. TCR-CD3 engagement for as little as 5 s induced
(B) CD3 is the major binding partner for the SH3.1 domain. The its association with Nck (Figure 4C, top), whereas the
indicated GST fusion proteins were used for pd from 35S-methionine level of tyrosine phosphorylation did not differ from that
Jurkat cell lysate. The position of the SH3.1 binding TCR-CD3 com-
of nonstimulated cells (Figure 4C, middle). Furthermore,plex is indicated with arrows, the positions of proteins binding to
immunoprecipitation of TCR-CD3 followed by immu-SH3.2 and SH3.3 with arrowheads.
noblotting with anti-phosphotyrosine did not reveal any(C) Nck, but not other SH3-containing proteins, binds to CD3. A
GST- pd was performed from Jurkat cell lysates and IB with anti- tyrosine phosphorylated CD3after 5 s activation (Figure
bodies for the indicated proteins. 4C, bottom); this was only clearly observed after 30
s. Thus, the change within the TCR-CD3 complex that
enables Nck recruitment precedes tyrosine phosphory-
lation of the ITAMs. Tyrosine phosphorylation of theprotein with only the SH2 domain did not bind (Figure
3A). When expressed individually as GST fusion pro- CD3 ITAM was not detected in these experiments. Fur-
ther evidence in favor of complete independence of Nck-teins, we found that only the amino-terminal SH3 domain
(SH3.1) is able to bind CD3 (Figure 3A). This binding CD3 binding from PTK activity was obtained by as-
Nck Recruitment by CD3
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Figure 4. Induction of TCR-CD3 Binding to Nck Is Independent of PTK Activation and Occurs before Tyrosine-Phosphorylated Proteins Are
Detected
(A) TCR-CD3 binding to Nck is independent of tyrosine phosphorylation. A pd with GST-SH3.1 was performed from nonstimulated (0 min),
UCHT1-stimulated (5 min), or pervanadate-stimulated (PV) Jurkat cells. IB was performed with anti-CD3 (top left). For evaluation of PTK
activity, IP and IB with anti-phosphotyrosine antibody 4G10 was performed from the same lysates (bottom left). Jurkat cells were stimulated
in the presence or absence of 20 M PP2, and the TCR-CD3-Nck association and evaluation of PTK activity revealed as above.
(B) PTK-independent recruitment of Nck to TCR-CD3. Flag-CD3 Jurkat cells were transfected with HA-Nck and activated as above, and the
association of Nck to CD3 revealed by IP with anti-Flag and IB with anti-HA.
(C) TCR-CD3 binding to Nck is detected before protein tyrosine phosphorylation. Jurkat cells were stimulated with UCHT1 for the indicated
times before pull-down with GST-Nck beads and IB with anti-CD3 (top). IP and IB with 4G10 was performed in parallel to show total tyrosine
phosphorylation (middle), and IP with UCHT1 and IB with 4G10 to show tyrosine-phosphorylated CD3 (bottom).
(D) Temperature dependence of TCR binding to Nck. Jurkat cells were stimulated with UCHT1 for 5 min at the indicated temperatures and
treated as above to show the association of the TCR with Nck and PTK activity.
sessing the temperature dependence of both. Total pro- and elute, under mild conditions, the whole TCR-CD3
tein tyrosine phosphorylation elicited upon TCR-CD3 complex (data not shown). Once purified, TCR-CD3 was
engagement was decreased at 24
C and 14
C and was incubated with UCHT1 before pull-down with GST-
completely prevented when cells were stimulated at 0
C SH3.1. This experiment showed that preincubation with
(Figure 4D). Nck binding was temperature independent. the anti-CD3 antibody induced a conformational change
in the purified TCR-CD3 complex that allowed its binding
to the Nck SH3.1 domain (Figure 5A). The monoclonalTCR-CD3 Engagement Induces a Conformational
antibody APA1/1 has been previously shown to bindChange that Exposes the Proline-Rich
near to the CD3 PRS (Borroto et al., 1998). Preincuba-Sequence in CD3
tion of antibody-engaged purified TCR-CD3 with APA1/1The inducible association of the CD3 PRS with the Nck
prevented binding to GST-SH3.1 (Figure 5A). In contrast,SH3.1 domain suggests a conformational change as the
APA1/2, an isotype-matched monoclonal antibody spe-mechanism responsible for exposure of the PRS. To rule
cific for the cytoplasmic tail of CD3 (Alarcon et al.,out contributions from other cellular factors, a cell-free
1991), had no effect.assay was performed with Jurkat T cells expressing an
To discount crosslinking as the cause of conforma-immunoglobulin single-chain fragment (Fv) appended to
tional change, a monovalent Fab fragment of UCHT1the N terminus of the TCR chain. The Fv fragment we
was prepared and incubated with purified TCR-CD3.used recognizes the haptens NP and NIP. By binding
Figure 5B shows that the Fab fragment induced thewith NP (low-affinity hapten) columns and eluting with
free NIP (high-affinity hapten), it was possible to purify conformational change in the TCR-CD3 complex that
Cell
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exposes CD3 for Nck binding. A different anti-CD3 anti-
body (OKT3), as a Fab fragment or intact antibody, was
also capable of inducing the conformational change
(Figure 5C). However, the TCR constant-region-spe-
cific antibody Jovi.1 (intact or Fab fragment) did not
induce binding to Nck, suggesting that not all TCR-CD3
ligands promote the conformational change. A scheme
of how ligand binding may promote both Nck recruit-
ment and PTK activation is shown in Figure 5D.
Recruitment of Nck to the TCR-CD3 Complex Is
Required for T Cell Activation
The currently accepted model of TCR-CD3 signaling
places Nck far downstream of the TCR-CD3 complex,
but the characterization of the Nck-CD3 interaction de-
scribed above places Nck as an immediate effector of
TCR-CD3 signaling. A first approach to investigate
whether Nck binding to TCR-CD3 plays an important
role in TCR-CD3 signaling was to study the activation
potency of Nck-CD3 interaction-inducing (OKT3) and
noninducing (JOVI.1) antibodies described above (Fig-
ure 5C). We found that OKT3 was a better inducer of
both IL-2 release and CD69 expression than JOVI.1,
and that this result was not significantly altered upon
crosslinking with a secondary antibody (Figure 6A). This
result correlated with the fact that in living cells OKT3
was also a better inducer of TCR-CD3 binding to Nck.
However, tyrosine phosphorylation was induced by both
antibodies with similar potency (see Supplemental Fig-
ures S1A and S1B at http://www.cell.com/cgi/content/
full/109/7/901/DC1). To further assess the role of Nck
recruitment to TCR-CD3 in T cell activation, we overex-
pressed the Nck SH3.1 domain, thereby occupying the
CD3 PRS and preventing interaction with endogenous
Nck. Jurkat T cells were stably transfected with a vector
expressing a SH3.1-EGFP fusion protein, and clones
expressing the highest levels were selected by flow cy-
tometry. Clones expressing EGFP or a full-length Nck-
EGFP fusion protein were selected as controls. We and
others have previously described how Jurkat T cells
stimulated on anti-CD3 antibody-coated coverslipsFigure 5. Binding of Stimulatory Antibody to Purified TCR-CD3 In-
spread within a few minutes, forming a ring of F actinduces a Conformational Change that Allows Binding to Nck
that rims the periphery of the cells (Borroto et al., 2000;(A) Antibody engagement of purified TCR-CD3 induces binding of
Bunnell et al., 2001). Since Nck is postulated to haveCD3 to Nck. The TCR-CD3 complex from the TCR-Fv-expressing
cell clone 31.13 scV3 was purified on NP-Sepharose columns and a role in the rearrangement of the actin cytoskeleton
eluted with free NIP. The purified complex was incubated with 50 (Buday, 1999), we performed a spreading assay to test
ng/ml stimulatory antibody UCHT1, and subsequently with 1 g/ml the effect of overexpressing SH3.1. Cells stably trans-
anti-CD3 antibody APA1/1 or 1 g/ml of the control anti-CD3 fected with SH3.1-EGFP were less extended and their
antibody APA1/2 before pd of TCR-CD3 with GST-SH3.1 and IB
actin cytoskeleton less polymerized than cells express-with anti-CD3.
ing EGFP (Figure 6B). It is notable that although the level(B and C) Monovalent Fab fragments of the anti-CD3 antibodies
UCHT1 and OKT3, but not of the anti-C antibody Jovi.1, induce of Nck-EGFP expression was lower than those of EGFP
the conformational change in TCR-CD3 that promotes Nck binding. or SH3.1-EGFP (data not shown), there was a clear po-
Purified TCR-CD3 from 31.13 scV3 cells (B) or a postnuclear super- tentiation of cell spreading. Similar effects were ob-
natant of Jurkat cells (C) were incubated with 50 ng/ml UCHT1 or served with transient transfection (data not shown).
50 ng/ml of its Fab fragment (B), or the indicated concentrations of
Cell spreading takes place within minutes of TCR-CD3complete or Fab fragments of OKT3, Jovi.1, and control antibody
anti-HA (C), before pd with GST-SH3.1 and IB with anti-CD3.
(D) Model of T cell activation by TCR-CD3. Antigen/MHC binding to
the variable regions of the TCR/ heterodimer promotes both TCR-
CD3 clustering and a conformational change in the TCR. TCR-CD3 PRS in CD3 (indicated as a boxed P) and Nck recruitment. A second
clustering would be necessary for the activation of TCR-CD3-asso- layer of intervention would be recruitment of the PTK ZAP70 and
ciated src kinases Lck and Fyn, which subsequently phosphorylate other signaling proteins to phosphorylated ITAMs, and the recruit-
the ITAMs (indicated as pinned boxes). Independent from PTK acti- ment of WASP, WIP, SLP76, and Pak to Nck. A dimeric model of
vation and crosslinking, a conformational change in the cytoplasmic the TCR is depicted (Fernandez-Miguel et al., 1999; San Jose et al.,
tails of the CD3 subunits is produced that results in exposure of the 1998).
Nck Recruitment by CD3
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Figure 6. Interference with Nck-CD3 Interaction Inhibits T Cell Activation
(A) Antibody-induced Nck-CD3 interaction correlates with T cell stimulation. Jurkat cells were stimulated for 48 hr with the indicated
concentrations of stimulatory antibodies JOVI.1 (circles) or OKT3 (squares) in the presence (closed symbols) or absence (open symbols) of a
3-fold higher concentration of a crosslinking (X-link) rabbit anti-mouse Ig antibody. After stimulation, cells were stained for CD69 expression,
and the supernatant was collected to measure IL-2 release.
(B) Overexpression of SH3.1 Nck inhibits TCR-induced actin polymerization and cell spreading. Jurkat T cells stably expressing EGFP-fused
forms of full-length Nck (Nck-EGFP), the Nck SH3.1 domain (SH3.1-EGFP), or empty vector (EGFP) were stimulated for 10 min on coverslips
coated with 25 g/ml UCHT1 (anti-CD3) or without antibody (poly-D-Lys). Cells were fixed and stained with Texas red-labeled phalloidin to
show the presence of F actin. The percentage of spreading was estimated by counting the number of flat cells and was 87% for EGFP-
transfected cells, 91% for Nck-EGFP-transfected cells, and 2% for SH3.1-EGFP-transfected cells.
(C) Effect of SH3.1 overexpression on superantigen-induced cytokine release. Jurkat T cells expressing the Nck-EGFP (triangles), SH3.1-EGFP
(circles), and EGFP (squares) constructs were stimulated for 24 hr with superantigen (SEE)-preloaded Raji APC. After stimulation, the supernatant
was collected to measure IL-2 and TNF- release.
(D) Transduction of antibody APA1/1 interferes with CD3 binding to Nck. Human PBMC were either mock-transduced or transduced with
APA1/1 before stimulation with UCHT1. Nck binding to TCR-CD3 was evaluated by precipitation with GST-SH3.1 and IB with anti-CD3. The
level of phospho-CD3 is shown at the bottom.
(E) Interference with Nck binding to CD3 inhibits T cell proliferation. Human PBMC transduced either with APA1/1 (squares), APA1/2 (triangles),
or anti-CD4 antibody HP2/6 (circles) were stimulated on UCHT1-coated plates. Forty-eight hours later, cell proliferation was estimated by 3H-
thymidine incorporation. The means and standard deviations of quadruplicated cultures are represented.
Cell
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triggering. To examine the effect of SH3.1 overexpression shown). We nonetheless investigated the effect of SH3.1
overexpression on the formation and maturation of theon later events, IL-2 release upon T cell stimulation with
plastic bound antibodies was measured. Similar to the IS. Immunostaining with anti-CD3 showed that TCR-
CD3 clustering in the IS was unaffected in SH3.1-EGFP-effect on cell spreading, the clone expressing Nck-EGFP
produced more IL-2 after TCR-CD3 triggering than the expressing cells compared with EGFP-expressing cells
(Figure 7C), indicating that the Nck-CD3 interaction isclone expressing EGFP alone, while the clone express-
ing SH3.1 produced none (see Supplemental Figure S1C not essential for TCR recruitment. We then examined
the association of PKCwith the IS. PKC is translocatedat http://www.cell.com/cgi/content/full/109/7/901/
DC1). To study cytokine release with a different stimulus, to the mature IS and is an indicator of IS maturity (Dustin
and Cooper, 2000; Monks et al., 1998). We found thatthe T cell clones were incubated with APCs preloaded
with the superantigen SEE, and IL-2 and TNF release PKC translocation to the IS was specifically prevented
by overexpression of SH3.1-EGFP (Figure 7C). Quantifi-into the culture supernatant was measured. Expression
of SH3.1 again had a strongly inhibitory effect, reducing cation revealed a 3-fold reduction in the number of con-
jugates in which PKC translocated to the IS (Figureor even blocking SEE-induced release of both cytokines,
while the clone transfected with full-length Nck secreted 7D). Thus the inhibition of TCR-CD3-mediated T cell
activation, attained upon overexpression of the CD3higher levels (Figure 6C).
Another approach to inhibit Nck-CD3 interaction was binding domain of Nck, appears to derive from a 2-fold
effect: a reduction in the number of T cell:APC conju-to transduce peripheral blood T cells with the antibody
APA1/1, which blocks the Nck-CD3 interaction by bind- gates, and an inhibition of IS maturation.
ing to the CD3PRS (Borroto et al., 1998). Unlike tyrosine
phosphorylation of CD3, the Nck-CD3 interaction was Discussion
inhibited in APA1/1-transduced cells, suggesting that
APA1/1 was blocking the CD3-PRS (Figure 6D). Inhibi- In this study we provide evidence that engagement of
tion of Nck-CD3 interaction correlated with a poorer the TCR-CD3 complex promotes a conformational
proliferation response to immobilized anti-CD3 antibody change resulting in the exposure of a proline-rich Nck
compared with cells transduced with control antibodies binding sequence (PRS) in CD3. Ligand-induced con-
(Figure 6E). Thus, blockade of the Nck interaction site formational changes in the TCR, similar to those found
in CD3, by overexpressing the Nck SH3.1 domain or in G protein-coupled receptors and the erythropoietin
transduction with a specific antibody, results in inhibi- receptor, have long been speculated (Janeway, 1995;
tion of T cell activation. Jiang and Hunter, 1999; Reth, 2001), although the evi-
dence was weak and indirect. The use of soluble forms
of MHC/antigen complexes has given strong supportOverexpression of the CD3 Binding Domain
of Nck Inhibits the Formation of T Cell:APC for TCR-CD3 oligomerization as a key event in TCR-CD3
signaling (Boniface et al., 1998; Cochran et al., 2000).Conjugates and the Maturation
of the Immune Synapse Stimulation of T cells with monovalent (Fab) forms of
anti-TCR-CD3 antibodies resulted in cocapping with theTo further investigate the mechanisms by which inhibi-
tion of Nck-CD3 interaction impairs T cell activation, coreceptor CD4, providing evidence that noncrosslink-
ing antibodies may promote changes in the T cell (Yoonwe analyzed the formation of T cell:APC conjugates.
TCR-CD3 signaling increases the avidity of integrin- et al., 1994). More recently, it was found that the cyto-
plasmic tail of CD3 might convert from a lipid boundmediated adhesion in a process dependent on polymer-
ization of the actin cytoskeleton (Dustin and Cooper, helical structure to an unfolded structure upon phos-
phorylation at tyrosine (Aivazian and Stern, 2000). These2000). As overexpression of the Nck SH3.1 domain inhib-
its actin polymerization induced upon TCR-CD3 trig- results are in agreement with earlier findings showing
that a synthetic peptide corresponding to the third ITAMgering, we predicted that the conjugate formation would
also be affected. This was confirmed by our finding that of CD3 adopts an -helical structure in its unphosphor-
ylated form and a  sheet conformation when phosphor-conjugate formation between Raji APC and Jurkat T
cells expressing SH3.1-EGFP did not increase upon ylated (Laczko et al., 1998). However, both these studies
were performed in cell-free systems with synthetic pep-TCR-CD3 triggering with SEE (Figure 7A). In contrast,
when control Jurkat cells (expressing EGFP) were used, tides and recombinant proteins, in the absence of other
subunits of the TCR-CD3 complex. The present studySEE increased conjugate formation.
Since the TCR-CD3 complex concentrates in the IS shows in living T cells that the TCR-CD3 complex under-
goes a conformational change that can be ascribed to(Dustin and Cooper, 2000; Monks et al., 1998), we next
analyzed whether recruitment of Nck by TCR-CD3 also a specific step: Nck binding to the PRS of CD3. Nck
interacts with free CD3, but not in the context of theresults in its recruitment to the IS. Live fluorescence
time-lapse confocal videomicroscopy revealed that TCR-CD3 complex unless this is engaged with a stimula-
tory antibody or antigen (Figure 1). Although the struc-full-length Nck-EGFP becomes concentrated to the IS
(Figure 7B and Supplemental Movies at http://www. tural basis of such a conformational change still remains
undetermined, one could propose that the cytoplasmiccell.com/cgi/content/full/109/7/901/DC1) over a time
course similar to TCR-CD3 recruitment (Krummel et al., tail of CD3 is in an unfolded state when in isolation, as
has been found in NMR studies (Borroto et al., 1997),2000, and data not shown). In a similar experiment with
SH3.1-EGFP-expressing cells, we could not see translo- but adopts a folded non-Nck binding structure within the
TCR-CD3 complex. Ligand binding to TCR-CD3 wouldcation of the construct to the IS in those few cells that
formed conjugates in the presence of SEE (data not then result in the CD3 tail readopting the unfolded
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Figure 7. Interference with Nck-CD3 Interaction Inhibits T Cell:APC Conjugate Formation and IS Maturation
(A) Raji cells were incubated with or without 5 g/ml SEE and mixed 1:1 with Jurkat T cells. Conjugates were adhered to poly-L-lysine-coated
coverslips and counted by direct examination by fluorescence microscopy. Bars represent the percentage of conjugates relative to the total
number of Raji cells. Mean  SEM of six independent experiments is shown.
(B) Raji cells labeled with CMTMR were incubated with SEE and settled onto fibronectin-coated coverslips. Jurkat cells expressing Nck-EGFP
were added, and individual live cells were monitored by time-lapse confocal microscopy imaging. Images were taken at 30 s intervals, and
representative images taken from the digital movie at the times indicated are shown. Each time point shows the DIC image overlaid with the
fluorescence images of Raji cells (red) and Nck-EGFP staining (green).
(C) Jurkat-Raji cell conjugates were formed as described in (A), then fixed and stained for TCR or PKC (images on the right, in red). On the
left is shown the corresponding DIC images superimposed on the blue staining of Raji cells.
(D) The percentage of conjugates with PKC accumulated at the contact area relative to the total number of conjugates was determined.
Mean  SEM of four independent experiments is shown.
structure, exposing the PRS. Alternatively, the PRS may solution of the extracellular domains of the CD3-CD3
dimer indicates that the subunits are associated throughbe hidden by the tails of other CD3 subunits and TCR-
CD3 engagement may lead to PRS exposure by promot- rigid rod-like connectors that may permit the displace-
ment of the transmembrane domains (Sun et al., 2001).ing rotation of the CD3-CD3 and CD3-CD3 dimers
around the transmembrane domain axis. Interestingly, A piston-like movement of the TCR/ heterodimer, as
shown for the aspartate receptor (Ottemann et al., 1999),antibody-mediated crosslinking of a protein chimera
consisting of the extracellular and transmembrane do- or its rotation with respect to the CD3 dimers could be
proposed as the primary events inducing the changesmains of CD8 fused to the cytoplasmic tail of CD3 did
not induce binding to Nck (data not shown). This could in the CD3 tails leading to exposure of the CD3-PRS.
Our data showing that monovalent Fab fragments ofbe interpreted as the rigidity imposed by the interchain
disulfide bond in the CD8/CD3 chimera preventing ex- anti-CD3 antibodies induce binding of purified TCR-CD3
to Nck strongly supports a conformational change inposure of the PRS.
The existence of a conformational change in the en- the CD3 subunits of the TCR-CD3 complex independent
of crosslinking. By analogy, recent data on the structuregaged TCR-CD3 complex could appear to contradict
crystallographic data showing a lack of correlation be- of the B cell antigen receptor suggest that a conforma-
tional change, rather than receptor crosslinking, is thetween structural changes in the TCR/ heterodimer
and the nature of the stimulating peptide/MHC ligands, mechanism by which this receptor transmits signals
across the plasma membrane (Reth, 2001; Schamel andincluding weak agonists and antagonists with different
affinities (Ding et al., 1999). However, this study was Reth, 2000).
The current model of TCR-CD3 signaling places acti-performed with a soluble TCR/ heterodimer in the
absence of CD3 subunits, and so does not exclude a vation of the PTK Lck and Fyn and phosphorylation of
the ITAMs by these kinases as the earliest activationligand-induced displacement of the TCR/ hetero-
dimer with respect to the CD3 dimers. The structure in events elicited upon TCR triggering, upon which the
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entire signal transduction cascade is pending (Lin and CD3 interaction with an antibody inhibits TCR-CD3-
Weiss, 2001). We show here that the conformational induced T cell proliferation. It therefore seems clear that
change that allows Nck recruitment occurs earlier than Nck plays a central role in TCR signaling and that this
and is independent of tyrosine kinase activity. However, is dependent on its direct binding to the CD3 chain of
it is unlikely that Nck recruitment to TCR-CD3 initiates the TCR-CD3 complex.
a separate signaling pathway, because Nck and some In conclusion, we have shown that, upon ligand en-
of its binding proteins, including SLP76, are tyrosine gagement, the CD3 subunits of the TCR-CD3 complex
phosphorylated (Buday, 1999; Lin and Weiss, 2001; undergo a conformational change that exposes the PRS
Yablonski et al., 1998). Therefore, it appears that the of CD3 and results in recruitment of Nck to the complex.
conformational change promoting Nck recruitment and TCR-CD3 can therefore elicit activation signals through
the activation of PTKs as a consequence of TCR-CD3 the inducible recruitment of a protein adaptor via a SH3
crosslinking soon come together into a common activa- domain. Disruption of the Nck-CD3 interaction inhibits
tion pathway. IS maturation and T cell activation, suggesting that Nck
The commonly held view of the role of Nck in T cell is necessary for the assembly of a signaling complex
signaling places it as a direct effector of the adaptor around the engaged TCR-CD3 complex. Further re-
SLP76 (Lin and Weiss, 2001). This adaptor, essential search is required to define the importance of Nck-CD3
for T cell activation, is a substrate of the TCR-CD3- interaction in the recruitment and activation of Nck ef-
associated PTK ZAP70 and becomes attracted to the fectors.
plasma membrane through the adapters LAT and Gads.
SLP76 forms a trimolecular complex with Vav (a guanine Experimental Procedures
nucleotide exchange factor for the Rho family GTPases
PlasmidsRac and Cdc42) and Nck (Lin and Weiss, 2001). In this
The sequence encoding the human CD3 cytoplasmic tail was ampli-way, Rac and Cdc42 can regulate effectors that interact
fied by PCR with end primers that add NcoI and SacI flanking restric-with Nck, including WASP and Pak. According to this
tion sites, and it was cloned into the plasmid pSOS (Stratagene) to
model, Nck is far downstream of TCR-CD3 and inter- yield pSOS-CD3. The construct pSOS-CD3 Tandem contained
venes only after SLP76 recruitment. Our results, how- two copies in tandem, head to tail, of the cytoplasmic tail of CD3.
ever, show that Nck is directly recruited to TCR-CD3. The constructs pGEX-4T1-GST-Nck and pGEX-4T1-GST-Ncktrn
were made by PCR of human Nck. The pGEX-4T1 derivatives GST-Since Nck uses only its first SH3 domain to interact with
Nck, GST-SH3.1, GST-SH3.2, and GST-SH3.3 were kindly pro-CD3, its other domains are potentially free to interact
vided by Dr. R. Geha (Children’s Hospital, Harvard Medical School,with Pak1 and/or WIP (second SH3 domain), with WASP
Boston) and GST-SH2 and the HA-tagged Nck and Nck by Dr.
(third SH3 domain), and with SLP76 through the SH2 X. Bustelo (Centro Nacional del Ca´ncer, Salamanca, Spain). The
domain (Buday, 1999). By simultaneously binding TCR- Ig- leader sequence, including the adjacent signal peptidase cleav-
CD3 and these important signaling proteins, Nck could age site and the sequence encoding the Flag tag, was amplified by
PCR with the vector pEVmb-1Nneo (Schamel and Reth, 2000). Theserve as a scaffold for the recruitment of signaling ef-
resulting fragment substituted the leader sequence of the humanfectors involved in the reorganization of the actin cy-
CD3 chains to yield the expression vectors pSRFlag-CD3, -CD3,toskeleton close to TCR-CD3. Experiments are now in
and -CD3. The cytoplasmic deletions of human CD3 were gener-progress to determine whether binding of Nck is impor- ated by loop-out mutagenesis, as described previously (Mallabia-
tant for SLP76 recruitment to TCR-CD3. barrena et al., 1992). PCR products encoding full-length Nck and
It is known that pharmacological disruption of actin SH3.1 were cloned into the expression vector pEGFP-N1 (Clontech)
filaments blocks T cell activation (Delon et al., 1998; to obtain the fusion proteins Nck-EGFP and SH3.1-EGFP.
Dianzani et al., 1992). This may be due to two important
Cells and Micefunctions of the actin cytoskeleton: the formation of the
The human T cell line Jurkat was maintained in complete RPMI 1640IS and the assembly of signaling complexes (Dustin and
supplemented with 10% fetal bovine serum (FBS; Sigma). COS-7Cooper, 2000). We demonstrate in this study that over-
cells were grown in DMEM supplemented with 5% FBS. Theexpression of the CD3 binding SH3 domain of Nck
TCR-negative Jurkat mutant line 31-13 and the Burkitt lymphoma
blocks TCR-CD3-induced actin polymerization and cell Raji cell line were kindly provided by A. Alcover (Institut Pasteur,
spreading. We also show that full-length Nck is rapidly Paris). The cell clone Flag-CD3 was obtained by transfection of
translocated to the IS and that overexpression of its pSR-Flag-CD3 into Jurkat cells. The cell clones expressing EGFP,
Nck-EGFP, and SH3.1-EGFP were obtained by transfection ofSH3.1 domain blocks the recruitment of PKC. There-
the corresponding plasmids into the Jurkat cell line J77cl20 (Nieder-fore, interference with Nck-CD3 association has conse-
gang et al., 1997). The cell line 31.13 scV3 was obtained by transfec-quences for the maturation and function of the IS. PKC
tion of 31-13 cells with a fusion of a V3 TCR chain and a single Fvactivity depends on Vav, and its recruitment to the IS
chain (W.W.A. Schamel et al., submitted; Schamel and Reth, 2000).
depends on the ability of Vav to induce actin polymeriza- Thymic and spleen cells were isolated from AND-TCR (Rag2	/	)
tion (Villalba et al., 2000). It is therefore quite likely that transgenic mice (Kaye et al., 1992).
the defective recruitment of PKC to the IS upon interfer-
ence with Nck-CD3 association arises from defective Antibodies and Reagents
construction of the actin scaffold. The anti-human mouse mAbs APA1/1, SP34, and APA1/2, which
recognize the CD3 cytoplasmic tail, the CD3 extracellular domain,It has recently been shown that mutation of the Nck
and the cytoplasmic tail of CD3, respectively, have been describedSH3.2 domain, which prevents association with Pak1,
previously (Alarcon et al., 1991), as have the rabbit anti-CD3 antise-inhibits NFAT activation in T cells (Yablonski et al., 1998).
rum 448 (San Jose et al., 1998) and the anti-human CD4 mouse
We have now shown that overexpression of the SH3.1 mAb HP2/6 (Mallabiabarrena et al., 1992). The mouse anti-CD3
domain, responsible for the association with CD3, in- UCHT1 and the anti-C Jovi.1 mAbs were kindly provided by Dr.
hibits T cell spreading and cytokine release induced P. Beverley (The Edward Jenner Institute for Vaccine Research,
Berkshire, UK) and Dr. M. Owen (CRUK, London, UK), respectively.by TCR-CD3 triggering. Furthermore, blockade of Nck-
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The anti-Lck antibody was a kind gift of Dr. V. Horejsi (Institute of all cases to monitor the delivery efficiency by flow cytometry. Rou-
tinely, 100% of cells were transduced.Molecular Genetics, Prague, Czech Republic). The anti-CD3 mono-
clonal antibody OKT3 was purchased from Ortho. Fab fragments
were prepared using the Immunopure IgG1 Fab Preparation kit from Functional Assays
Pierce. Rabbit anti-Nck antibody was obtained from Pharmingen. For cell spreading, Jurkat T cell clones were stimulated by incuba-
Other mouse mAbs were purchased as follows: anti-Crk, anti-Grb2, tion for 10 min on UCHT1-coated coverslips. For antibody coating,
anti-HS1, and anti-Dlg from Transduction Laboratories, anti-phos- coverslips were treated with poly-D-lysine (Borroto et al., 2000).
photyrosine (4G10) from Upstate Biotechnology, anti-HA (12CA5) After permeabilization with 0.1% saponine, F actin was visualized
from Roche Molecular Biochemicals, and anti-Flag (M2) from Sigma. by staining with Texas red-labeled phalloidin (Sigma). Images were
S. aureus enterotoxins A and E (SEA and SEE) were from Toxin analyzed with a Zeiss Radiance 2000 confocal microscope.
Technologies, and the inhibitor of Src family kinases (PP2) was from To measure cytokine release, Jurkat T cells were stimulated on
Calbiochem. UCHT1-coated 96-well plates for 24 hr, and the cell culture superna-
tant was assayed for cytokine release with the Human Th1/Th2
Cytokine Cytometric Bead Assay kit (Pharmingen). Alternatively,Yeast Two-Hybrid Screening
Jurkat cells (5  105 /ml) were incubated 1:1 with SEE-loaded RajiThe Cytotrap System (Stratagene) was used to screen a human
cells for 24 hr, and the cell culture supernatant was assayed forspleen cDNA library (Stratagene) for new interaction partners for
cytokine release as above. For SEE loading, Raji cells were incu-the cytoplasmic tail of CD3. Yeast were cotransformed with the
bated with 5 g/ml SEE for 30 min before use.library and the pSOS-CD3 Tandem construct according to the sup-
To measure TCR-induced T cell proliferation, antibody-trans-plier’s instructions, and three million cotransformed clones were
duced PBMC (100,000 cells per point) were incubated on anti-CD3screened. Of 319 putative positive clones selected by growth on
precoated 96-well plates for 24 hr. A volume of 1Ci of [3 H]thymidinegalactose at 37
C, 304 were discarded as revertants due to their
(Amersham) per well was then added, and the incorporation of thisability to grow on glucose at 37
C. Plasmids from nonrevertant colo-
metabolite was measured 24 hr later.nies were isolated by transforming E. coli and selecting on chloram-
phenicol. Yeast were then cotransformed with these candidate li-
Conjugate Formation and Time-Lapse Fluorescencebrary plasmids plus one among pSOS (empty vector), pSOS-CD3
Confocal Microscopycytoplasmic tail, or pSOS-CD3Tandem to detect bait-dependent
Time-lapse confocal microscopy and conjugate formation ofgrowth. Two clones were selected and tested for specificity of inter-
J77c120 Jurkat T cells stimulated with SEE-loaded Raji APCs wasaction with the CD3 cytoplasmic tail by cotransformation with the
performed as described (Montoya et al., 2002).control pSOS constructs provided with the system. Both clones
were found to be specific and were DNA sequenced. One of the
clones corresponded to human Nck and included the whole pro- Acknowledgments
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